These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 19686799)

  • 1. The influence of microglia on the pathogenesis of Parkinson's disease.
    Long-Smith CM; Sullivan AM; Nolan YM
    Prog Neurobiol; 2009 Nov; 89(3):277-87. PubMed ID: 19686799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation.
    Teismann P; Schulz JB
    Cell Tissue Res; 2004 Oct; 318(1):149-61. PubMed ID: 15338271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease.
    Kim S; Moon M; Park S
    J Endocrinol; 2009 Sep; 202(3):431-9. PubMed ID: 19570816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?
    Rogers J; Mastroeni D; Leonard B; Joyce J; Grover A
    Int Rev Neurobiol; 2007; 82():235-46. PubMed ID: 17678964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress and inflammation in Parkinson's disease: is there a causal link?
    Hald A; Lotharius J
    Exp Neurol; 2005 Jun; 193(2):279-90. PubMed ID: 15869932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-synuclein induces migration of BV-2 microglial cells by up-regulation of CD44 and MT1-MMP.
    Kim S; Cho SH; Kim KY; Shin KY; Kim HS; Park CH; Chang KA; Lee SH; Cho D; Suh YH
    J Neurochem; 2009 Jun; 109(5):1483-96. PubMed ID: 19457162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glial reactions in Parkinson's disease.
    McGeer PL; McGeer EG
    Mov Disord; 2008 Mar; 23(4):474-83. PubMed ID: 18044695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodegeneration and inflammation in Parkinson's disease.
    Phani S; Loike JD; Przedborski S
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S207-9. PubMed ID: 22166436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action.
    Kim YJ; Park HJ; Lee G; Bang OY; Ahn YH; Joe E; Kim HO; Lee PH
    Glia; 2009 Jan; 57(1):13-23. PubMed ID: 18661552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroinflammatory processes in Parkinson's disease.
    Hirsch EC; Hunot S; Hartmann A
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S9-S15. PubMed ID: 15885630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune processes in the pathogenesis of Parkinson's disease - a potential role for microglia and nitric oxide.
    Członkowska A; Kurkowska-Jastrzebska I; Członkowski A; Peter D; Stefano GB
    Med Sci Monit; 2002 Aug; 8(8):RA165-77. PubMed ID: 12165754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic role of glial cells in Parkinson's disease.
    Teismann P; Tieu K; Cohen O; Choi DK; Wu DC; Marks D; Vila M; Jackson-Lewis V; Przedborski S
    Mov Disord; 2003 Feb; 18(2):121-9. PubMed ID: 12539204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
    Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
    Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease.
    Collins LM; Toulouse A; Connor TJ; Nolan YM
    Neuropharmacology; 2012 Jun; 62(7):2154-68. PubMed ID: 22361232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra.
    Arimoto T; Choi DY; Lu X; Liu M; Nguyen XV; Zheng N; Stewart CA; Kim HC; Bing G
    Neurobiol Aging; 2007 Jun; 28(6):894-906. PubMed ID: 21887889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease.
    Marinova-Mutafchieva L; Sadeghian M; Broom L; Davis JB; Medhurst AD; Dexter DT
    J Neurochem; 2009 Aug; 110(3):966-75. PubMed ID: 19549006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glatiramer acetate could be a potential therapeutic agent for Parkinson's disease through its neuroprotective and anti-inflammatory effects.
    Tsai SJ
    Med Hypotheses; 2007; 69(6):1219-21. PubMed ID: 17548170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electro-acupuncture stimulation protects dopaminergic neurons from inflammation-mediated damage in medial forebrain bundle-transected rats.
    Liu XY; Zhou HF; Pan YL; Liang XB; Niu DB; Xue B; Li FQ; He QH; Wang XH; Wang XM
    Exp Neurol; 2004 Sep; 189(1):189-96. PubMed ID: 15296849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra.
    Ferrari CC; Pott Godoy MC; Tarelli R; Chertoff M; Depino AM; Pitossi FJ
    Neurobiol Dis; 2006 Oct; 24(1):183-93. PubMed ID: 16901708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory priming of the substantia nigra influences the impact of later paraquat exposure: Neuroimmune sensitization of neurodegeneration.
    Mangano EN; Hayley S
    Neurobiol Aging; 2009 Sep; 30(9):1361-78. PubMed ID: 18187236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.